Skip to main content
Log in

Author's concluding statement

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Usonis, V., Bakasenas, V., Kaufhold, A., Chitour, K., Clemens, R.: Reactogenicity and immunogenicity of a novel live attenuated combined measles, mumps and rubella vaccine in healthy children. Ped. Infect. Dis. J. 18 (1999) 42–48.

    Article  CAS  Google Scholar 

  2. Farrington, P., Pugh, S., Colville, A., Flower, A., Nash, J., Morgan-Capner, P., Rush, M., Miller, E.: A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345 (1995) 567–569.

    Article  PubMed  CAS  Google Scholar 

  3. Kimura, M., Kuno-Sakai, H., Yamazaki, S., Yamada, A., Hishiyama, M., Kamiya, H., Ueda, K., Murase, T., Hirayama, M., Oya, A., Nozaki, S., Murata, R.: Adverse events assocaited with MMR vaccines in Japan. Acta Paediatr. Jpn. 38 (1996) 205–211.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Usonis, V. Author's concluding statement. Infection 27, 134–135 (1999). https://doi.org/10.1007/BF02560516

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02560516

Keywords

Navigation